Safety Profile stories:
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting...
Oct 8th, 2009 - Forbes
BusinessWire - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend...
Novartis MS Pill Works, But Safety Concern Remains
Apr 29th, 2009 - Wall Street Journal
(Adds detail, analyst comment, recasts lede) ZURICH (Dow Jones)--Novartis AG (NVS) said Wednesday new study results showed its experimental multiple sclerosis pill FTY720 worked better than a rival drug...



